MedTrace Logo

EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study

NCT03120195 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-01-29

No results posted yet for this study

Summary

The aim of this study is to assess the safety and feasibility of the EndoRotor® for the ablation of Barrett's esophagus.

Conditions

  • Barretts Esophagus With Dysplasia

Interventions

DEVICE

The EndoRotor®

The EndoRotor® is in automated mechanical endoscopic mucosal resection system for use in the gastrointestinal tract. The EndoRotor suctions up the tissue and cuts it, automatically sending the tissue to a collection trap for histological evaluation.

Sponsors & Collaborators

  • Interscope, Inc.

    collaborator INDUSTRY

  • Foundation for Liver Research

    lead OTHER

Principal Investigators

  • Arjun D. Koch, MD, PhD · Erasmus MC, University Medical Center Rotterdam

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-27
Primary Completion
2019-01-21
Completion
2019-06-18

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03120195 on ClinicalTrials.gov